Crescendo Biologics out-licenses 'Humabody' asset to Zai Lab
Zai Lab and Crescendo Biologics have signed a licensing agreement under which Zai Lab will develop protein therapeutics for inflammatory indications.
Archives for May 30, 2018
Celltrion resubmits Rituxan candidate in US, Herceptin version to follow
Celltrion has resubmitted its Rituxan biosimilar candidate for approval following the US FDA’s rejection in April.
Prothena cuts jobs, focuses on Roche and Celgene collaborations
Prothena Corporation has announced plans to restructure its neuroscience pipeline and lay off 57% of its workers.